Muscle mass ultrasound study in cirrhosis patients
Part of Brain & nervous system, Hormones & metabolism clinical trials.
This study uses ultrasound to measure muscle mass in people with cirrhosis. It aims to understand muscle changes and their link to health outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with cirrhosis of the liver.
- You are being followed at the University Hospital of Antwerp.
- You are willing to participate in the study.
- You have not had a decision made to stop treatment within the next 24 hours.
- You have been cancer-free (including liver cancer) for at least 12 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether measuring certain proteins in your blood (myokines) can help detect muscle loss (sarcopenia) in people with liver cancer, and compares these blood tests to special CT scans. If you're newly diagnosed with liver cancer and have a CT scan already, you may be able to join.
This study looks at how loss of muscle strength or mass (sarcopenia) relates to advanced liver disease. It may help doctors understand which patients are at higher risk and could guide future care choices.
This study looks at how loss of muscle mass (sarcopenia) affects the course of illness in people with gastrointestinal cancers, liver cirrhosis, or those in the ICU. It will help doctors better understand and treat muscle wasting.
This study uses ultrasound and body-composition imaging to measure muscle health in people receiving kidney transplants. The goal is to better understand and prevent muscle loss, a common problem after transplant.
This study looks at the gut microbiome (the helpful bacteria in your gut) and muscle loss (sarcopenia) in people with liver cirrhosis. It may help researchers understand what changes in the gut and body can go along with getting weaker, so better treatments can be developed.
This study looks at how your body uses protein in your muscles when you have cirrhosis (a scarred liver). It uses a special “tracer” method (a substance that can be tracked) and may help researchers better understand muscle loss in people with milder cirrhosis.
Hear when a new Sarcopenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.